AR106057A1 - Composición con efecto antiviral, composición farmacéutica - Google Patents
Composición con efecto antiviral, composición farmacéuticaInfo
- Publication number
- AR106057A1 AR106057A1 ARP160102836A ARP160102836A AR106057A1 AR 106057 A1 AR106057 A1 AR 106057A1 AR P160102836 A ARP160102836 A AR P160102836A AR P160102836 A ARP160102836 A AR P160102836A AR 106057 A1 AR106057 A1 AR 106057A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- pharmaceutical composition
- antiviral effect
- viral infection
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15185764 | 2015-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR106057A1 true AR106057A1 (es) | 2017-12-06 |
Family
ID=54151132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160102836A AR106057A1 (es) | 2015-09-17 | 2016-09-16 | Composición con efecto antiviral, composición farmacéutica |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3349741A1 (de) |
AR (1) | AR106057A1 (de) |
DE (1) | DE202016008745U1 (de) |
EA (1) | EA039000B1 (de) |
UA (1) | UA123054C2 (de) |
WO (1) | WO2017046312A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021198504A1 (de) * | 2020-04-02 | 2021-10-07 | Inflamed Pharma Gmbh | Wirkstoffe zur medizinischen verwendung |
LU101724B1 (de) * | 2020-04-02 | 2021-10-04 | Inflamed Pharma Gmbh | Wirkstoffe zur medizinischen Verwendung |
EP4091608B1 (de) * | 2021-05-21 | 2024-04-17 | Medice Arzneimittel Pütter GmbH & Co. KG | Zusammensetzung mit antiviraler wirkung |
EP4275681A1 (de) * | 2022-05-10 | 2023-11-15 | inflamed pharma GmbH | Wirkstoffe zur medizinischen verwendung |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19823319A1 (de) * | 1998-05-26 | 1999-12-02 | Karl Engelhard, Fabrik Pharm.- Praeparate Gmbh & Co. Kg | Topisch anwendbares Arzneimittel zur Behandlung von Virusinfektionen |
DE19823318A1 (de) * | 1998-05-26 | 1999-12-02 | Karl Engelhard, Fabrik Pharm.- Praeparate Gmbh & Co. Kg | Verwendung eines Arzneimittels mit einem Gehalt an Tyrothricin zur Behandlung von Virusinfektionen |
-
2016
- 2016-09-16 DE DE202016008745.3U patent/DE202016008745U1/de active Active
- 2016-09-16 AR ARP160102836A patent/AR106057A1/es unknown
- 2016-09-16 WO PCT/EP2016/071944 patent/WO2017046312A1/de active Application Filing
- 2016-09-16 UA UAA201803866A patent/UA123054C2/uk unknown
- 2016-09-16 EA EA201890653A patent/EA039000B1/ru unknown
- 2016-09-16 EP EP16767247.6A patent/EP3349741A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP3349741A1 (de) | 2018-07-25 |
EA201890653A1 (ru) | 2018-08-31 |
EA039000B1 (ru) | 2021-11-19 |
WO2017046312A1 (de) | 2017-03-23 |
UA123054C2 (uk) | 2021-02-10 |
DE202016008745U1 (de) | 2019-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY37581A (es) | Compuestos para el tratamiento de la infección por virus de la hepatitis b | |
UY37252A (es) | Compuestos para el tratamiento de infección por virus de la hepatitis b | |
CL2020000685A1 (es) | Nucleósidos sustituidos, nucleótidos y análogos de estos. | |
SV2018005610A (es) | Derivados de oxopiridina sustituidos | |
CL2019000415A1 (es) | Compuestos terapéuticos útiles para el tratamiento profiláctico o terapéuticos de una infección por el virus del vih. | |
CL2016002414A1 (es) | Compuestos derivados de nucleosidos, inhibidores de la transcriptasa inversas composición farmacéutica que los comprende y su uso en el tratamiento de una infección por vih. pct | |
CO2017002170A2 (es) | Terapia de combinación para tratar un paramixovirus | |
CL2016000952A1 (es) | Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
EP4233898A3 (de) | Influenza-mrna-impfstoffe | |
CL2016000493A1 (es) | Inhibidores de polimerasa hcv. | |
CL2016002971A1 (es) | Combinación. | |
EA201790597A1 (ru) | Способы лечения вирусных инфекций filoviridae | |
CO2019009215A2 (es) | Sal hemi-sulfato de nucleótido para el tratamiento del virus de la hepatitis c | |
GT201500020A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2016001936A1 (es) | Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2018001226A1 (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer | |
CR20130620A (es) | 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina | |
PE20180260A1 (es) | Metodos y kits para tratar la depresion | |
CL2014001599A1 (es) | Compuestos derivados de nucleosidos sustituidos en 4’-azido, 3’-fluoro o sus sales, como inhibidores de la replicacion del rna del vhc; composicion farmaceutica que los comprende; y su uso para el tratamiento o la profilaxis de la infeccion por el virus de la hepatitis c (vhc). | |
BR112015024411A2 (pt) | desaza-purinonas macrocíclicas para o tratamento de infeções virais | |
EA201690687A1 (ru) | Ингибиторы репликации вируса иммунодефицита | |
DOP2016000253A (es) | Nuevos compuestos | |
DOP2016000336A (es) | Derivados de isoindolina para uso en el tratamiento de una infeccion viral | |
AR106057A1 (es) | Composición con efecto antiviral, composición farmacéutica | |
BR112017026061A2 (pt) | composto, uso de um composto, e, método de tratamento de uma infecção viral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |